🔴 Connect Biopharma is trading 7.67% down in pre-market as Nasdaq Composite falls 1.54%

Connect Biopharma is trading 7.67% down at $1.88 after broader pre-market weakness.

• The Nasdaq Composite is down 1.54%, with no new company-specific announcement identified for September 14, 2026.
• Management’s H.C. Wainwright presentation is scheduled for September 15, 2026; topline Phase 2 Seabreeze STAT data remain expected during September.
• The decline follows a recent volatile period, including a 30.07% drop on September 3; current evidence points to global risk-off sentiment rather than a fresh company catalyst.